IRVINE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone ...
IRVINE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果